✦ LIBER ✦

Carboplatin (CBDCA) plus etoposide (VP-16) in non small cell lung cancer (NSCLC) treatment

✍ Scribed by Bernardo, G.; Bernardo, A.; Plastina, M.; Strada, M.R.; Brunetti, G.; Pozzi, U.; Rossi, A.; Garcia, B.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Carboplatin (CBDCA), ifosfamide (IFX) an

✍ Candamio, S.; Menéndez, M.D.; Irigoyen, A.; Barón, F.J.; Vázquez, F.; Cueva, J.F 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 267 KB

Carboplatin (CBDOA) plus etoposide (VP16

✍ Crinò, L.; De Marinis, F.; Clerici, M.; Meacci, M.; Cocconi, G.; Malacarne, P.; 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 131 KB

Navelblne (NVB), oral etoposide (VP16),

✍ López, J.O.; Federico, C. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 267 KB

Carboplatin plus VP-16 with simultaneous

📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 121 KB

Dose escalation study of carboplatin (CB

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 162 KB

102 Navelbine (NVB), oral etoposide (VP1

✍ López, J.O.; Federico, C. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 162 KB